Stem Cultures LLC
Albany, NY
- UEI
- P4JPYMXCHB43
- CAGE
- 6NPM8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 150 New Scotland Ave, Albany, NY 12208, USA
- Website
- stemcultures.com
- Founded
- 2012
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Custom growth factor-releasing beads purchase | National Institute on Drug Abuse (NIH) | $25,000 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Stembiosys Inc. | San Antonio, TX | 238990 All Other Specialty Trade Contractors |
| Link Biosystems Inc. | Irvington, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Isurtec | Saint Paul, MN | 541713 Research and Development in Nanotechnology |
| Human Cell Co | Naperville, IL | — |
| Trailhead Biosystems Inc. | Beachwood, OH | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Stem Cultures LLC is a company that specializes in stem cell growth factors for controlled release. It has developed a technology that encapsulates growth factors such as Activin A, BDNF, EGF, GDNF, and FGF2 for controlled release delivery. The company is registered as a self-certified small disadvantaged business, for-profit organization, and limited liability company in the System for Award Management (SAM.gov).
Stem Cultures LLC has received prime federal contract awards for providing custom growth factor-releasing beads. In 2020, the company received a purchase order worth $24,999.99 from the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences for custom growth factor-releasing beads. The award did not involve any set-aside designation.
Stem Cultures LLC has also received prime federal grant awards for developing controlled-release microbeads to replace growth factors in fetal bovine serum. In 2023, the company was awarded a $903,045.00 project grant from the Department of Health and Human Services National Institutes of Health National Institute of General Medical Sciences to develop a defined insert for sustainable culture (DISC™) device providing controlled-release human recombinant growth factors to support the growth of human retinal pigment epithelial (RPE) cells. The goal is to replace fetal bovine serum (FBS) growth factors with a bioengineered DISC™ device, addressing concerns about FBS and improving the reproducibility of cell production. In 2021, Stem Cultures LLC received a $676,503.00 project grant from the same agency to manufacture controlled-release poly lactic-co-glycolic acid (PLGA) microbeads that slowly release growth factors to produce defined and stable growth factor levels in culture media, facilitating the development of an FBS-free medium.
SBA capabilities narrative
Sustained Release Growth Factors
FGF2, EGF, Activin-A, VEGF, BMP4, etc
Quick answers
Is Stem Cultures LLC registered in SAM.gov?
Yes. Stem Cultures LLC's SAM.gov registration is active through March 3, 2027.
What is Stem Cultures LLC's most recent federal award?
Stem Cultures LLC's most recent federal grant award is Controlled-release microbeads to replace growth factors in fetal bovine serum - scientific abstract: the frequent use… (R42GM142345), from National Institute of General Medical Sciences (NIH), on April 1, 2023.
On GovTribe
See Stem Cultures LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors